FINAL PROGRAMME - Esc-archive.eu

Scientific Programme Friday, May 23, 2003
11.30–12.30 Auditorium I
36
Oral Session: Acute Stroke – Treatment Concepts
Chairs: F. Aichner, Austria and M. Kaste, Finland
11.30–11.40 The usefulness of clinical DWI mismatch in the treatment of acute
ischemic stroke with reperfusion therapies
A. Dávalos, R. Leira, S. Pedraza, M. Blanco, J. Serena, Y. Silva,
M. Castellanos, J. Castillo, Hospital Universitari Doctor Josep Trueta, Spain
11.40–11.50 Clinical and radiological predictors of recanalisation and outcome
in 40 patients with acute basilar artery occlusion treated with
intra-arterial thrombolysis
M. Arnold, K. Nedeltchev, R.W. Baumgartner, L. Remonda, G. Schroth,
T.J. Loher, F. Stepper, M. Sturzenegger, H.P. Mattle, University of Berne,
Switzerland
11.50–12.00 Thrombin-activable fibrinolysis inhibitor (TAFI) level is related to
t-PA-induced recanalisation resistance after ischemic stroke
J. Montaner, J. Monasterio, C.A. Molina, M. Ribó, J.F. Arenillas, F. Pujadas,
J. Alvarez-Sabín, Neurovascular Research Laboratory, Stroke Unit,
Vall d'Hebron Hospital, Spain
12.00–12.10 Degree of tPA-induced proximal MCA recanalisation differs among
stroke subtypes
C.A. Molina, E. Santamarina, J. Montaner, J.F. Arenillas, M. Ribo, R. Huertas,
J. Mauriño, J. Alvarez-Sabin, Hospital Vall d'Hebron, Spain
12.10–12.20 Beyond the three hour time-window: multivariable patient-selection
for thrombolytic therapy in acute ischemic stroke
D. Kent, R. Ruthazer, E. Bluhmki, H. Selker, Division of Clinical Care Research,
Tufts New England Medical Center, USA
12.20–12.30 Improved disability endpoint selection for use in acute stroke trials
F.B. Young, K.R. Lees, C.J. Weir, University of Glasgow, United Kingdom